Figure 4From: Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study Adjusted mean FEV 1 over 3 years by baseline post-bronchodilator FEV 1 % predicted.Back to article page